Literature DB >> 3486561

Staging of bladder carcinoma: MRI-CT-surgical correlation.

M A Amendola, G M Glazer, H B Grossman, A M Aisen, I R Francis.   

Abstract

Eleven patients with transitional cell carcinoma of the bladder were examined with spin-echo MRI using a superconductive magnet operating at a field strength of 0.35 T. MRI results were compared with the CT findings in 10 of the patients. All subjects later underwent radical cystectomy including pelvic lymph-node dissection. MRI accuracy for staging was 64% using the TNM classification and 73% by the Jewett-Strong-Marshall system while CT accuracy was 40%. MRI provided improved demonstration of tumor invasion of perivesical fat planes, prostate, and seminal vesicles and greater anatomic detail was afforded by direct sagittal and coronal views.

Entities:  

Mesh:

Year:  1986        PMID: 3486561     DOI: 10.2214/ajr.146.6.1179

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Authors:  Jack Crozier; Nathan Papa; Marlon Perera; Brian Ngo; Damien Bolton; Shomik Sengupta; Nathan Lawrentschuk
Journal:  World J Urol       Date:  2018-08-17       Impact factor: 4.226

Review 2.  Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT.

Authors:  J O Barentsz; G J Jager; J A Witjes; J H Ruijs
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging.

Authors:  Ahmed El-Assmy; Mohamed E Abou-El-Ghar; Ahmed Mosbah; Ahmed R El-Nahas; Huda F Refaie; Ihab A Hekal; Tarek El-Diasty; El Housseiny Ibrahiem
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

4.  The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells.

Authors:  Chunhu Yu; Ying Wang; Tiejun Liu; Kefu Sha; Zhaoxia Song; Mingjun Zhao; Xiaolin Wang
Journal:  Onco Targets Ther       Date:  2020-05-14       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.